Acer therapeutics announces full enrollment of pivotal bioequivalence trial of acer-001 for urea cycle disorders

Topline trial results expected in q1 2021; targeting a pre-nda meeting with fda in q2 2021 topline trial results expected in q1 2021; targeting a pre-nda meeting with fda in q2 2021

ACER Ratings Summary

ACER Quant Ranking